Dignity Health St. J
Dignity Health St. Joseph’s Hospital and Medical Center launches new initiative to address health disparities of African Americans with chronic kidney disease
February 27, 2023 16:08 ET | Dignity Health St. Joseph's Hospital and Medical Center
PHOENIX, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Dignity Health St. Joseph’s Hospital and Medical Center has launched a new initiative to address race-based algorithms in early diagnosis of chronic kidney...
TODAY: CMS Controver
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
October 12, 2022 12:27 ET | UsAgainstAlzheimer's
Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- With the federal government’s decision to deny Medicare coverage of an entire class of Alzheimer’s treatments, as well as the promising clinical...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering
January 12, 2022 16:41 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it commenced its previously announced fully...
Interpace Biosciences Announces Executive Transition: Jack Stover to Retire as President and Chief Executive Officer Thomas Burnell Appointed as Successor
November 25, 2020 08:12 ET | Interpace Biosciences, Inc.
Parsippany, NJ, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December...
Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care
February 11, 2020 09:00 ET | Cognoa
PASADENA and PALO ALTO, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Autism Learning Partners ("ALP"), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
March 29, 2017 08:02 ET | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...